|
Prescription Drug Search
Strengths available for Lialda:
Browse Alphabetically:
A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
#
Information about CancerDrugsDirect.com
List of countries where we can ship Lialda:
- Albania
- Aruba
- Australia
- Bangladesh
- Belgium
- Bulgaria
- Cayman Islands
- Chile
- Denmark
- El Salvador
- Estonia
- France
- Germany
- Gibraltar
- Greenland
- Guam
- Honduras
- India
- Iraq
- Ireland
- Italy
- Jamaica
- Japan
- Latvia
- Lebanon
- Mauritius
- Netherlands
- Panama
- Poland
- Qatar
- Russian Federation
- Seychelles
- Singapore
- Slovakia
- Sweden
- Taiwan
- Thailand
- United Kingdom, UK
- United States, US
- Vanuatu
Latest news releases on Lialda:
Watson Confirms Lialda® Patent Challenge - Yahoo Finance
PARSIPPANY, N.J., May 9, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (WPI) today confirmed that its subsidiary, Watson Laboratories, Inc. - Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug ...
Watson Pharma Confirms Lialda Patent Challenge - NASDAQ
(RTTNews.com) - Watson Pharmaceuticals, Inc. (WPI) confirmed Wednesday that its subsidiary, Watson Laboratories, Inc. - Florida, has filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market ...
Watson and Shire in Legal Battle - Analyst Blog - NASDAQ
According to the IMS Health data, sales of Lialda in the U.S. amounted to $390 million for the 12 months ended March 31, 2012. Last month, Watson Pharma was in another patent infringement lawsuit, when the company announced the filing of an ANDA ...
Shire, Cosmo and Giuliani International file suit against Watson over generic Lialda - News-Medical.Net
Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc. - Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market ...
Shire Plc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report - new company profile report - Transworld News
The company's major products include VYVANSE, INTUNIV, EQUASYM, RESOLOR, PENTASA, LIALDA, FOSRENOL, CALCICHEW, REPLAGAL, ELAPRASE and XAGRID. Major products in the pipeline are JUVISTA, SPD 547, and HGT-1110, among others. Its products are extensively used ...
